Technology
Cloud Pharmaceuticals delivers novel molecular designs of ligands to your druggable targets using our Quantum Molecular Design process deployed on cloud-based high performance computing platforms. The process is run by Cloud Pharmaceuticals' experts in a high-throughput production environment and has three components:
Download an overview of the process:
Quantum Molecular Design >
Download our white paper:
Accurate In Silico Prediction of Ligand Binding Potency in Therapeutic Targets using Quantum Molecular Design >
Read the cover story:
CLOUD COMPUTING - Using Quantum Molecular Design & Cloud Computing to Improve the Accuracy & Success Probability of Drug Discovery >
Drug Development & Discovery
March 2016
- An artificial Intelligence search of virtual chemical space
- Highly accurate binding affinity prediction
- Chemical property filters for drug-like properties, safety, and synthesizability
Download an overview of the process:
Quantum Molecular Design >
Download our white paper:
Accurate In Silico Prediction of Ligand Binding Potency in Therapeutic Targets using Quantum Molecular Design >
Read the cover story:
CLOUD COMPUTING - Using Quantum Molecular Design & Cloud Computing to Improve the Accuracy & Success Probability of Drug Discovery >
Drug Development & Discovery
March 2016
